AU2003266622A1 - Medicinal composition for inhibiting increase in blood gastrin concentration - Google Patents

Medicinal composition for inhibiting increase in blood gastrin concentration

Info

Publication number: AU2003266622A1
Authority: AU; Australia
Prior art keywords: medicinal composition; inhibiting increase; gastrin concentration; blood gastrin; blood
Prior art date: 2002-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003266622A

Other versions

AU2003266622A8 (en

Inventor

Masahiko Hagihara

Keiichi Ito

Nobuhiko Shibakawa

Atsuyuki Tomizawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sankyo Co Ltd

Ube Corp

Original Assignee

Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-25

Filing date

2003-09-25

Publication date

2004-04-19

2003-09-25 Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd

2004-04-19 Publication of AU2003266622A1 publication Critical patent/AU2003266622A1/en

2004-04-19 Publication of AU2003266622A8 publication Critical patent/AU2003266622A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003266622A 2002-09-25 2003-09-25 Medicinal composition for inhibiting increase in blood gastrin concentration Abandoned AU2003266622A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002-278551		2002-09-25
JP2002278551		2002-09-25
PCT/JP2003/012263 WO2004029058A1 (en)	2002-09-25	2003-09-25	Medicinal composition for inhibiting increase in blood gastrin concentration

Publications (2)

Publication Number	Publication Date
AU2003266622A1 true AU2003266622A1 (en)	2004-04-19
AU2003266622A8 AU2003266622A8 (en)	2004-04-19

Family

ID=32040430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003266622A Abandoned AU2003266622A1 (en)	2002-09-25	2003-09-25	Medicinal composition for inhibiting increase in blood gastrin concentration

Country Status (3)

Country	Link
AU (1)	AU2003266622A1 (en)
TW (1)	TW200420293A (en)
WO (1)	WO2004029058A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT97467A (en) *	1990-04-27	1992-01-31	Byk Gulden Lomberg Chem Fab	METHOD FOR PREPARING NEW PYRIDAZINS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0559837B1 (en) *	1990-11-26	1995-10-25	The Procter & Gamble Company	Shaped solid made with a rigid, interlocking mesh of neutralized carboxylic acid
US5534515A (en) *	1991-10-25	1996-07-09	Byk Gulden Lomberg Chemische Fabrik Gmbh	Pyrrolopyridazines having gastrointestinal protective effects
ES2185693T3 (en) *	1994-01-19	2003-05-01	Sankyo Co	DERIVED FROM PIRROLOPIRIDACINA.
SE9704404D0 (en) *	1997-11-28	1997-11-28	Astra Ab	New compounds
TWI287014B (en) *	1999-06-15	2007-09-21	Sankyo Co	Optically active pyrrolopyridazine compound
CN1285593C (en) *	2000-02-10	2006-11-22	三共株式会社	Pyrrolopyridazine compound
JP2002068992A (en) *	2000-08-25	2002-03-08	Ito En Ltd	Eradicating agent for helicobacter pylori, and food, beverage or food additive having this eradicating effect
JP3387066B2 (en) *	2000-12-14	2003-03-17	三共株式会社	Anti-ulcer agent containing pyrrolopyridazine compound
JP2003119140A (en) *	2001-08-08	2003-04-23	Sankyo Co Ltd	Pharmaceutical agent containing pyrrolopyridazine compound

2003
- 2003-09-25 WO PCT/JP2003/012263 patent/WO2004029058A1/en not_active Application Discontinuation
- 2003-09-25 TW TW092126425A patent/TW200420293A/en unknown
- 2003-09-25 AU AU2003266622A patent/AU2003266622A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004029058A1 (en)	2004-04-08
AU2003266622A8 (en)	2004-04-19
TW200420293A (en)	2004-10-16

Publication	Publication Date	Title
GB2394894B (en)	2005-08-31	New use for pharmaceutical composition
AU2003291103A8 (en)	2004-06-15	Pharmaceutical composition
IL173639A (en)	2010-12-30	Ppar-activating compound and pharmaceutical composition containing same
IL164547A0 (en)	2005-12-18	Pharmaceutical composition
IL165878A0 (en)	2006-01-15	Pharmaceutical composition
HK1093896A1 (en)	2007-03-16	Medicinal composition
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2003280799A1 (en)	2004-06-15	Medicinal composition
AU2003215767A1 (en)	2003-10-08	Devices for use in medicine
AU2003266622A1 (en)	2004-04-19	Medicinal composition for inhibiting increase in blood gastrin concentration
AU2003235931A1 (en)	2003-11-11	Vintoperol-containing medicinal composition for transdermal administration
AU2003280678A1 (en)	2004-05-25	Medicinal composition
AU2001287884A1 (en)	2002-04-02	Halogen compounds for use in medicine
AU2003257814A1 (en)	2004-02-25	Medicinal composition for lowering blood lipid level
AU2003252701A1 (en)	2004-02-16	Medicinal composition for treating thrombopenia
AUPS188302A0 (en)	2002-05-30	Pharmaceutical composition
EP1547593A4 (en)	2009-12-23	Medicinal composition
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
GB0208324D0 (en)	2002-05-22	Administration of beneficial substances
AU2003205702A1 (en)	2003-09-02	Cefquinome composition for intra-mammary administration in cattle
GB0201891D0 (en)	2002-03-13	Pharmaceutical composition
GB0213306D0 (en)	2002-07-24	Pharmaceutical composition
GB0228111D0 (en)	2003-01-08	Pharmaceutical composition
GB0227342D0 (en)	2002-12-31	Pharmaceutical composition
GB0214491D0 (en)	2002-08-07	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2005-06-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase